IRWD today
$4.87+$0.06 (+1.25%)close Nov 11, 2026Trend
DailyDowntrend (starting)
4 hourExpanding
1 hourStrong Bullish
15 minBearish
5 minConsolidating
Daily trend turns up above $5.78
Key levels
Resistance$5.13
Resistance$4.88
Support$4.59
Support$4.22
Latest news & SEC filings
EarningsIronwood Pharmaceuticals posts Q3 2026 results, lifts full-year 2026 guidance
EarningsIronwood Pharmaceuticals holds Q3 2026 earnings call
GuidanceIronwood Pharmaceuticals lifts FY2026 sales guidance to $485M-$510M
SEC FilingIronwood Pharmaceuticals Inc filed a report on a major company event (Form 8-K)
All IRWD news →About Ironwood Pharmaceuticals
Ironwood Pharmaceuticals is a biotechnology company focused on digestive and rare diseases. Its main marketed medicine is linaclotide, sold under the LINZESS and CONSTELLA brand names in North America, Europe and Asia for constipation-related conditions. The company is also developing apraglutide for a rare malabsorption disorder, and it works with partners such as AbbVie, AstraZeneca and Astellas to commercialize its products globally.
Based on the company's 10-K filed Feb 26, 2026.
Nasdaq · Healthcare
IRONWOOD PHARMACEUTICALS INC (IRWD)
What Is the Price Target for IRWD?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is IRWD a Buy or Sell Right Now?
Thesis
- •Revenue growing -15.7% YoY with DECLINING trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for IRWD.
Start Free Trial →Is IRWD Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/E Forward, PEG
Fair Value
$17.13
15
Moat Score
NONE
4/9
Piotroski Score
-3.7
Altman Z-Score
What Is Smart Money Doing with IRWD?
Insider Signal
SELLING
0 buys / 14 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| DENNER ALEXANDER J | director | Buy | 3,694 | - | Sep 15, 2026 |
| Silver Ronald | officer | Buy | 25,000 | - | May 19, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →IRWD Growth Story
Revenue YoY
-15.7%
3yr Revenue CAGR
-10.3%
EPS Growth YoY
1400%
FCF Growth YoY
N/A%
Revenue Trend
DECLINING
Dark Pool Trades for IRWD
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for IRWD, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:01:02 | $4.87 | 1,038 | $$5K | BUY |
| 21:00:09 | $4.87 | 2,911 | $$14K | BUY |
| 21:00:00 | $4.87 | 1,276 | $$6K | BUY |
| 20:59:39 | $4.86 | 1,944 | $$9K | MIDPOINT |
| 20:59:31 | $4.86 | 3,000 | $$15K | BUY |
5 dark pool trades shown · $$49K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for IRWD
PREVIEWSEPT Investing provides real-time options flow tracking for IRWD, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $5 | Feb 19 | 100 | $$350 | 5 | SWEEP |
| CALL | $5 | Feb 19 | 100 | $$630 | 9 | SWEEP |
| CALL | $7.5 | Feb 19 | 100 | $$85 | 5 | SWEEP |
| CALL | $7.5 | Feb 19 | 100 | $$153 | 9 | SWEEP |
| CALL | $5 | Dec 18 | 37 | $$645 | 15 | SWEEP |
5 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for IRONWOOD PHARMACEUTICALS INC (IRWD) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →IRWD — frequently asked questions
What is IRWD stock price today?
IRONWOOD PHARMACEUTICALS INC (IRWD) is at $4.87, up 1.25% (+$0.06) at the Nov 11, 2026 close.
Why is IRWD stock moving today?
Latest IRWD news — Nov 5, 2026: Ironwood Pharmaceuticals posts Q3 2026 results, lifts full-year 2026 guidance · Nov 5, 2026: Ironwood Pharmaceuticals holds Q3 2026 earnings call
What do analysts rate IRWD?
Analyst ratings for IRWD: 2 Buy, 2 Hold, 0 Sell — consensus Buy.
Did IRWD beat earnings?
IRWD last reported on Aug 6, 2026: EPS $0.31 vs $0.32 expected — a miss of 3.1%.
What is IRWD's P/E ratio?
IRWD trades at a P/E of 4.8 vs a Healthcare average of 18.5.
Does IRWD pay a dividend?
IRWD does not currently pay a dividend.
What are IRWD support and resistance levels?
Support: $4.59, $4.22, $3.96. Resistance: $4.88, $5.13, $5.57.
What are insiders doing with IRWD?
Insider activity: SELLING, 0 buys and 14 sells in the last 90 days.
What is the latest news on IRWD?
Nov 5, 2026: Ironwood Pharmaceuticals posts Q3 2026 results, lifts full-year 2026 guidance · Nov 5, 2026: Ironwood Pharmaceuticals holds Q3 2026 earnings call · Nov 5, 2026: Ironwood Pharmaceuticals lifts FY2026 sales guidance to $485M-$510M